drugset / Trial / NCT01041274
DECIFER: Depression and Citalopram In First Episode Recovery
Phase 4
Completed
95 enrolled
NYU Langone Health
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study seeks to examine the effectiveness of citalopram added to treatment with any oral or injectable second-generation antipsychotic plus standardized psychoeducation in first episode schizophrenia patients. Because depressive symptoms are common in first episode patients, we will test the hypothesis that adding the SSRI citalopram to a pre-established medication regimen will improve quality of life and decrease relapse and suicidality over the course of a 12-month trial.
Timeline
- Start
- 2010-01
- Primary completion
- 2014-12
- Completion
- 2018-03-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Citalopram | Small molecule | 40 mg | Oral |